As of 2026-04-30, the Relative Valuation of Pfizer Inc (PFE) is 24.78 USD. This relative valuation is based on P/E multiples. With the latest stock price at 26.26 USD, the upside of Pfizer Inc based on Relative Valuation is -5.6%.
The range of the Relative Valuation is 20.95 - 32.13 USD.
| Range | Selected | |
| Trailing P/E multiples | 17.4x - 23.5x | 18.5x |
| Forward P/E multiples | 15.7x - 20.1x | 18.2x |
| Fair Price | 20.95 - 32.13 | 24.78 |
| Upside | -20.2% - 22.4% | -5.6% |
| Date | P/E |
| 2026-04-29 | 19.22 |
| 2026-04-28 | 19.38 |
| 2026-04-27 | 19.61 |
| 2026-04-24 | 19.76 |
| 2026-04-23 | 19.52 |
| 2026-04-22 | 19.62 |
| 2026-04-21 | 19.99 |
| 2026-04-20 | 20.14 |
| 2026-04-17 | 20.17 |
| 2026-04-16 | 19.92 |
| 2026-04-15 | 19.90 |
| 2026-04-14 | 19.84 |
| 2026-04-13 | 20.01 |
| 2026-04-10 | 19.71 |
| 2026-04-09 | 19.92 |
| 2026-04-08 | 20.11 |
| 2026-04-07 | 19.84 |
| 2026-04-06 | 20.37 |
| 2026-04-02 | 20.73 |
| 2026-04-01 | 20.90 |
| 2026-03-31 | 20.55 |
| 2026-03-30 | 20.33 |
| 2026-03-27 | 19.79 |
| 2026-03-26 | 20.18 |
| 2026-03-25 | 19.97 |
| 2026-03-24 | 19.73 |
| 2026-03-23 | 19.60 |
| 2026-03-20 | 19.74 |
| 2026-03-19 | 20.06 |
| 2026-03-18 | 20.00 |
| 2026-03-17 | 20.09 |
| 2026-03-16 | 19.48 |
| 2026-03-13 | 19.46 |
| 2026-03-12 | 19.66 |
| 2026-03-11 | 19.98 |
| 2026-03-10 | 19.88 |
| 2026-03-09 | 19.62 |
| 2026-03-06 | 19.80 |
| 2026-03-05 | 19.48 |
| 2026-03-04 | 19.49 |
| 2026-03-03 | 19.46 |
| 2026-03-02 | 19.95 |
| 2026-02-27 | 20.24 |
| 2026-02-26 | 19.84 |
| 2026-02-25 | 19.83 |
| 2026-02-24 | 19.87 |
| 2026-02-23 | 19.81 |
| 2026-02-20 | 19.51 |
| 2026-02-19 | 19.66 |
| 2026-02-18 | 20.03 |